Opportunity Information: Apply for PAR 18 405
The NHLBI Program Project Applications (P01 - Clinical Trials Optional) funding opportunity (PAR 18-405) is a National Institutes of Health discretionary grant designed to support large, coordinated research programs that fit squarely within the mission of the National Heart, Lung, and Blood Institute. The scientific scope is broad across cardiovascular, pulmonary, hematologic, and sleep research, covering both fundamental mechanisms and disease-focused work involving the heart, blood and lymphatic vessels, lungs, and blood. It also explicitly welcomes areas such as transfusion medicine, blood resources, implementation science, health disparities research, and translational research, as long as the overall program addresses NHLBI priorities. Clinical trials are allowed but not required, which gives applicants flexibility to propose basic, translational, clinical, or mixed portfolios depending on what best answers the central research question.
At the core of this announcement is the Program Project Grant (PPG) model, which is meant to fund collaboration that produces more than the sum of its parts. Applicants must propose at least three interrelated research projects that are scientifically connected and built around a single, clearly defined biomedical theme or complex research question. The expectation is not simply that multiple projects sit under the same umbrella, but that they actively interact, inform one another, and create real thematic integration. NHLBI supports this structure because it believes coordinated teams can accelerate discovery more effectively than separate, loosely related projects funded independently. To help the overall program run efficiently, applicants may also include shared core units when justified. These cores are intended to create economy of effort, space, and equipment, for example by centralizing specialized methods, shared instrumentation, data resources, clinical coordination functions, or other cross-cutting capabilities that directly support multiple projects.
A notable emphasis in the FOA is the encouragement of new scientific directions within P01 programs. NHLBI views the P01 mechanism as a way to stimulate innovative, forward-looking program concepts and to bring in scientists who have not traditionally received NHLBI support. The program environment is also framed as a training ground for leadership: it can help emerging scientific leaders learn how to organize and manage a complex, multi-project research program. In line with that, applicants have the option to include a research project led by an Early Stage Investigator (ESI), offering a structured way to integrate newer investigators into a major collaborative effort while still maintaining the program’s overall coherence and rigor.
Eligibility spans a wide range of organization types. Eligible applicants include various levels of government (state, county, city/township, special districts), independent school districts, public housing authorities/Indian housing authorities, public and private institutions of higher education, nonprofits (with or without 501(c)(3) status), for-profit organizations other than small businesses, and small businesses. The FOA also highlights additional eligible categories such as Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, regional organizations, U.S. territories or possessions, eligible federal agencies, and tribal governments or organizations, including Indian/Native American Tribal Governments other than federally recognized entities in the categories specified. On the international side, non-domestic (non-U.S.) entities (foreign organizations and foreign institutions) are not eligible to apply directly, and non-domestic components of U.S. organizations are not eligible to apply. However, foreign components are permitted when they meet the NIH definition in the NIH Grants Policy Statement, meaning a U.S.-based applicant can include a foreign component if it is scientifically justified and compliant with NIH policy.
From an administrative standpoint, the opportunity is issued by NIH under CFDA numbers 93.233, 93.837, 93.838, 93.839, and 93.840, reflecting the NHLBI research domains it supports. The funding instrument is a grant and the activity category is health. The source record notes an original closing date of 2020-12-02 and a creation date of 2017-10-20; applicants typically need to verify current submission dates, budgets, and any updated policies by checking the live FOA and NIH guidance, since P01 opportunities often use standard receipt cycles or updated reissues. Overall, this FOA is best suited for teams proposing a tightly integrated, multi-project program with a strong unifying theme, clear evidence of synergy across projects, and (where appropriate) shared cores that make the collaboration more efficient and scientifically productive.Apply for PAR 18 405
- The National Institutes of Health in the health sector is offering a public funding opportunity titled "NHLBI Program Project Applications (P01 - Clinical Trials Optional)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.233, 93.837, 93.838, 93.839, 93.840.
- This funding opportunity was created on 2017-10-20.
- Applicants must submit their applications by 2020-12-02. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Browse more opportunities from the same category: Health
Next opportunity: Maternal Nutrition and Pre-pregnancy Obesity: Effects on Mothers, Infants and Children (R01 Clinical Trial Optional)
Previous opportunity: Human Heredity and Health in Africa (H3Africa): Ethical, Legal, and Societal Issues (ELSI) Collaborative Centers (U54)
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PAR 18 405
Applicants also applied for:
Applicants who have applied for this opportunity (PAR 18 405) also looked into and applied for these:
| Funding Opportunity |
|---|
| Maintaining Immunity After Immunization (U01 - Clinical Trial Optional) Apply for RFA AI 17 034 Funding Number: RFA AI 17 034 Agency: National Institutes of Health Category: Health Funding Amount: $450,000 |
| Technology to Detect, Monitor and Assess Daily Functions in Individuals with Cognitive Decline, Alzheimer's Disease and/or Alzheimer's Disease Related Dementias (AD/ADRD) (R43/R44 Clinical Trial Not Allowed) Apply for PAR 18 329 Funding Number: PAR 18 329 Agency: National Institutes of Health Category: Health Funding Amount: $350,000 |
| Technology to Detect, Monitor and Assess Daily Functions in Individuals with Cognitive Decline, Alzheimer's Disease and/or Alzheimer's Disease Related Dementias (AD/ADRD) (R41/R42 Clinical Trial Not Allowed) Apply for PAR 18 326 Funding Number: PAR 18 326 Agency: National Institutes of Health Category: Health Funding Amount: $350,000 |
| Immunity in the Elderly (R01) Clinical Trial Optional Apply for RFA AI 17 037 Funding Number: RFA AI 17 037 Agency: National Institutes of Health Category: Health Funding Amount: $300,000 |
| Enhancing Central Neural Control of Mobility in Aging (U01 Clinical Trial Optional) Apply for RFA AG 18 019 Funding Number: RFA AG 18 019 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Single-Site Investigator-Initiated Clinical Trials (R61/R33 Clinical Trial Required) Apply for PAR 18 406 Funding Number: PAR 18 406 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Role of Peripheral Proteostasis on Brain Aging and Alzheimer's Disease (R01 Clinical Trial Not Allowed) Apply for RFA AG 18 020 Funding Number: RFA AG 18 020 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Clinical Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative UG3/UH3) - Clinical Trial Required Apply for PAR 18 407 Funding Number: PAR 18 407 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Data Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative U24 Clinical Trial Required) Apply for PAR 18 410 Funding Number: PAR 18 410 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Research Grants Using the Resources from the Osteoarthritis Initiative (OAI) (R21) - Clinical Trial Not Allowed Apply for PA 18 408 Funding Number: PA 18 408 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Research Grants Using the Resources from the Osteoarthritis Initiative (OAI) (R01) - Clinical Trial Not Allowed Apply for PA 18 409 Funding Number: PA 18 409 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Mentored Career Development Award to Promote Faculty Diversity in Biomedical Research (K01) - (Clinical Trials Not Allowed) Apply for RFA HL 18 026 Funding Number: RFA HL 18 026 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Accelerating Program Achievements to Control the Epidemic (APACE) in South Africa Apply for 72067418RFA00001 Funding Number: 72067418RFA00001 Agency: South Africa USAID-Pretoria Category: Health Funding Amount: $600,000,000 |
| Clarifying the Relationship between Delirium and Alzheimers Disease and Related Dementias (R01 Clinical Trial Optional) Apply for PAR 18 029 Funding Number: PAR 18 029 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIBIB Biomedical Technology Resource Centers (P41 Clinical Trials Optional) Apply for PAR 18 205 Funding Number: PAR 18 205 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Phase III Clinical Trials for the Spectrum of Alzheimer's Disease and Age-related Cognitive Decline (R01 Clinical Trial Required) Apply for PAR 18 028 Funding Number: PAR 18 028 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIA Revision and Resubmission Program Project Applications (P01 Clinical Trial Optional) Apply for PAR 18 030 Funding Number: PAR 18 030 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Global Infectious Disease Research Administration Development Award for Low-and Middle-Income Country Institutions (G11-Clinical Trial Not Allowed) Apply for PAR 18 335 Funding Number: PAR 18 335 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Phenotypic and Functional Studies on FOXO3 Human Longevity Variants to Inform Potential Therapeutic Target Identification Research (R01 Clinical Trial Optional) Apply for PAR 18 026 Funding Number: PAR 18 026 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Complex Integrated Multi-Component Projects in Aging Research (U19 Clinical Trial Optional) Apply for PAR 18 296 Funding Number: PAR 18 296 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PAR 18 405", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
